Search

Author/Creator Muslumanoglu, M.

2. Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy. (March 2019)

Authors:
Cabioglu, N.; Onder, S.; Oner, G.; Karatay, H.; Özkurt, E.; CanTrablus, D.; Tukenmez, M.; Muslumanoglu, M.; Saip, P.; Yavuz, E.
Journal:
Breast
Issue:
Volume 44(2019)Supplement 1
Page Start:
S40
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Factors Determining Local Recurrence in Locally Advanced Breast Cancer Patients who Received Neoadjuvant Chemotherapy and Breast Conserving Surgery. (April 2018)

Authors:
Can Trabulus, D.; Ozturk, E.; Cabioglu, N.; Dogan, S.; Tukenmez, M.; Emirikci, S.; Igci, A.; Ozmen, V.; Dinccag, A.; Muslumanoglu, M.
Journal:
European journal of cancer
Issue:
Volume 92(2018)Supplement 3
Page Start:
S118
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Predictive Factors to Achieve Pathologic Complete Response in Patients with Locally Advanced Breast Cancer in Decision Making for more Conservative Management. (April 2018)

Authors:
Can Trabulus, D.; Ozkurt, E.; Tukenmez, M.; Onder, S.; Muslumanoglu, M.; Igci, A.; Ozmen, V.; Dinccag, A.; Aydiner, A.; Cabioglu, N.
Journal:
European journal of cancer
Issue:
Volume 92(2018)Supplement 3
Page Start:
S113
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search